🆕🔥Mind blowing!
Among 6.3 million adults admitted to 241 US hospitals
50% of all anti-MRSA & antipseudomonal β-lactam prescribing was for suspected community onset sepsis but only 9.5% of pts treated with broad-spectrum Abx had (+) cx for MRSA,PSA or MDR
https://t.co/lqcuXeIWOW
Registration is now open for the 4th Annual ALIDS Antimicrobial Stewardship Conference‼️ Sign-up today for #ALIDS2024 🤩🧫💊
📍 The Valley Hotel, Homewood, AL
📆 Saturday, July 20
⏰ 8 AM - 3 PM CST
📚 FREE CE
🔗 https://t.co/XyDuLRqvnk
Dr. Anel Couzo representing @UABPharmRes with her data on “Identifying institution specific risk factors for Pseudomonas aeruginosa & MRSA pneumonia” at #MADID2024
Mark your calendars for ALIDS Antimicrobial Stewardship Conference 🎉
📆 Saturday, July 20
⏰ 8 AM - 3 PM
📍 Homewood, AL
📚 4 hours of FREE CE
A big thanks to @MAD_ID_ASP for co-promoting this event for us. Be sure to register for their meeting at https://t.co/JGF1KIem79
@ewood_1875@auhcop It was an honor and a pleasure to speak to these students, and it’s always exciting to visit the loveliest village on the plains! I definitely saw some stewards 👀 and the future looks bright!😎
❤️ Happy Valentines Day #IDtwitter#IDxPosts
Our friends still don’t know what we do
Bless our Gram-stained hearts
PK/PD Queens and Kings
Of all the moving parts
Bugs and drugs and MICs
Negotiating, planting seeds
In vitro wants, in vivo dreams
Grace our Gram-stained hearts
Interactions, ADRs
Combing notes and checking MARs
Delabeling allergies (au revoir!)
Delights the Gram-stained heart
Relearning that which we were taught
Data diving, answers sought
Framing unrequested thoughts
And baring Gram-stained hearts
Working with Doctors, APPs
Nurses and Lab – our Phamily
Case management, Micro, ICP!
Makes strong our Gram-stained hearts
We bring to bear all that we know
Waging wars on tiny foes
To aid a cure, to heal, and so
Sustain our Gram-stained hearts
@ShorterSeddonRx credit 🤓
New study concluded use of #ModelInformedPrecisionDosing & single-concentration monitoring improved overall outcomes among patients receiving AUC-guided #vancomycin for culture-proven gram-positive infections compared to trough-guided therapy: https://t.co/fAtTbxWGZN @UABMedicine
Guidelines from @acog continue to recommend amp/gent+/-clinda for intraamniotic infections. This observational study in @CIDJournal strongly suggests that cefoxitin would be just as good -- and maybe better. Time for a guidelines change? @julie_justo https://t.co/EtIGm2bqNd
In @OFIDJournal, Nicole Hall, PharmD, and colleagues evaluated the safety and efficacy of AUC-guided vancomycin therapy using MIPD and single-concentration monitoring.
Read: https://t.co/ehsS6BAB2z
Honored to be part of the team that helped make all this possible for our patients and institution. Still much work to do to 📉 unnecessary vancomycin use…but improved safety is reassuring, when use is indicated or not. @SEdwardsPharmD@NicoleHPharmD@UABPharmRes@UAB_ID
Incredibly proud of @NicoleHPharmD for the hard work put into this project! Getting here was a huge team effort, and so many advantages of the vancomycin dosing and monitoring strategy described are becoming more and more evident. 👏👏 https://t.co/mVqf5tWq4v